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Abstract: This study was involved with
determining the prevalence of diabetic
nephropathy in 72 Turkish children with
insulin-Dependent diabetes mellitus. Diabetic
nephropathy was diagnosed with blood
pressure levels, glomerular filtration rate,
albumin excretion rate, β-2 microglobulinuria
and kidney length. There wereo significant
differences between laboratory data for boys
and girls, but adolescent patients had
significantly higher albumin excretion rates
than preadolescent patients (p<0.05). The
mean kidney length of the diabetic patients
was 1-2 cm longer than in health children.

with insulin-dependent diabetes mellitus was
5.5%. Four patients who were diagnosed as
having diabetic nephropathy were given ACE
inhibitors and were put under strict
metabolic control. The progression of the
disease reversed in two patients. However, in
the other two end stage renal failure
developed. This may be due to some
unexplained genetic factor as well as the
patients’ ages.

It was found that the prevalence of clinical
diabetic nephropathy in pediatric patients

Key Words: İnsulin-dependent diabetes
mellitus, diabetic nephropathy, prevalence.
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Introduction
Although the long-term complications of insulindependent diabetes mellitus (IDDM) have long been
recognized (1, 2), the population-based epidemiologic
data of complications have not yet been determined in the
Turkish pediatric population. The major cause of
morbidity and mortality of IDDM is diabetic nephropathy
in young patients (1, 2). Owing to advances in the
diagnosis and treatment of diabetic nephropathy, its
management has become more effective and is now
initiated earlier after the presence of microalbuminuria
has been established.
This paper focuses on determining the prevalence of
nephropathy in diabetic patients who were followed up in
our pediatric endocrinology clinics. The preliminary data
obtained forced us to change our conventional protocol
for improving metabolic control in order to prevent
nephropathy.

In order to prevent diabetic nephropathy the
conventional two dose insulin regimen was
abandoned and a new intensive insulin
regimen was adopted.

followed up at the pediatric endocrinology clinic, aged
between 5 and 16 (mean 12.7±6.8). All received
conventional therapy of mixed-split insulin by two daily
injections of insulin. Their glucose was monitored and
they received education for nutritional planning and
exercise.
Blood pressure was measured in the sitting position
on each visit after a 5-minute rest, with an ordinary
mercury sphygmonometer with appropriately sized cuffs.
Blood samples were taken for serum glucose,
glycosylated hemoglobin (HbA1c), serum creatinine, BUN,
albumin, electrolytes. The 24-hour urine samples were
collected for creatinine clearance, albumin excretion rate
(AER) and β-2 microglobulinuria. The glomerular
filtration rate (GFR) was calculated and

Material and Methods
This cross-sectional study involved a total of 72
diabetic patients, 31 girls and 41 boys, who were
169
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Table 1.

The Clinical and Laboratory Data of the 72 Diabetic Subjects.

Total diabetic

Girls

Boys

Preadolescent patients

Adolescent patients

(n:72)

(n:31)

(n:41)

(n:30)

(n:42)

Mean age (year)

12.7±6.8

12.9±4.1

11.9±7.4

8.3±2.9

14.7±2.5

Mean duration of diabetes (year)

4.5±3.1

4.4±2.2

3.8±2.3

3.4±1.7

5.0±2.5

HbA1c(%)

9.5±4.3

9.4±3.9

9.8±4.4

9.1±4.6

9.8±3.6

Insulin dosage (U/kg)

0.7±0.2

0.8±0.3

0.6±0.2

0.6±0.2

0.8±0.3

121±32.4

120.5±21.7

122±41.8

136.5±43.3

115.0±12.7

110.1±10.5

110.5±11.6

109.9±9.5

104.3±13.4

122.2±7.5*

Glomerular filtration rate (ml/min/1.73)
Blood pressure (mm/Hg): systolic
diastolic

64.7±11.5

63.6±11.0

65.6±11

62.5±6.9

74.3±113

120±118.4

125±114.4

116±120.3

94.4±114.4

154.4±110*

β-2 microglobulin (mg/L)

0.6±0.5

0.7±0.2

0.6±0.5

0.9±2.5

0.3±0.2

Kidney length (cm)

93.7±3.0

-

-

92.5±5.8

95.6±1.9

Kidney length of healthy childen (cm)

92.1±2.9

-

-

91.5±4.6

94.5±2.7

Albumin excretion rate (µg/min)

Adolescent patients have significantly higher blood pressure and AER than preadolescent patients (*p<0.05).

Case 1

Case 2

Case 3

Case 4

Duration of diabetes (year)

9

12

1.5

2

Age (year)

14

16

16

15

Sex

M

F

F

F

Systolic blood pressure (mmHg)

130

135

130

135

Diastolic blood pressure (mmHg)

90

95

85

90

Glomerular filtration rate (mm/min/1.73)

58

65

40

48

Albumin excretion rate (µg/min)

250

245

260

310

Table 2.

The
Initial
Clinical
and
Laboratory Data of the 4
Nephropathic Diabetic Patients.

corrected for 1.73 m2 body surface area. The
baseline AER was calculated from the mean of the three
24-hour urine samples.

calculated for each subject. As a control, two sex-age
matched healthy children’s kidney length was measured
for each diabetic patient.

HbA1c was measured with latex agglutination
methods (Bayer Diagnostic). Urinary albumin and β-2
migroglobulin were measured by double antibody
radioimmunoassay (Pharmacia).

The statistical analyses were performed with the
Mann Whitney-U test.

Kidney ultrasonography was performed with a renal
time scanner with a 3.5 MHZ transducer. Kidney lengths
were measured bilaterally and mean kidney lengths were
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Results
The study involved 72 patients with IDDM. The
demographic and laboratory data of the subjects are
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Figure.

shown in Table 1.
There were no significant differences between the
demographic and laboratory data for boys and girls,
although girls had a slightly higher albumin exretion rate
(p>0.05). Preadolescent patients had higher GFR and
urinary β-2 microglobulin levels than adolescent patients,
but this was not statistically significnat (p>0.05).
Adolescent patients had significantly higher blood
pressure and AER than preadolescent patients (p<0.05).
Although there were no significant differences between
the kidney lengths of diabetic and healthy subjects
(p>0.05), the mean kidey length of the diabetic patients
was 1-2 cm longer even if sex and age was taken into
consideration.
Of the 72, 4 patients were considered as having
diabetic nephropathy. Their laboratory data is shown in
table 2. The prevalence of diabetic nephropathy was
found to be 5.5% in our population.
Discussion
Nephropathy is a diabetes-specific complication
associated with the highest mortality. Nephropathy
develops in 35-45% of cases of IDDM. The natural
history of clinically detectable diabetic nephropathy in
IDDM begins with the development of microalbuminuria
(30-300 mg albumin per 24 hours) which may occur as
early as five years after the onset of diabetes. This stage
of incipient nephropathy may be more likely in patients

Renal scintignophy shows marked
cortical uptake defects.

with glomerular hyperfiltration (glomerular filtration rate
>150 ml per minute). Overt proteinuria (>500 mg of
protein per liter, equivalent to 300 mg of albumin per 24
hours) develops in patients after another 5 to 10 years of
diabetes. Hypertension invariably develops during this
period. The appearance of persistent proteinuria and
hypertension is considered clinically overt nephropathy.
Although the prevalence of diabetic nephropathy in IDDM
patients has been studied with large series in the world,
population-based studies in Turkey have not been carried
out (1-5).
Several studies showed elevated GFR in IDDM similar
to our findings. Elevation of GFR is a phenomenon that
occurs with hyperglycemia, but appears to be
multifactorial (6). GFR was found to decline with long
duration of diabetes in our series. This might not be
considered clinical nephropathy because the levels of GFR
were still within the normal range except in four patients.
We studied the excretion of albumin as a marker of
the glomerular dysfunction and excretion of β-2
microglobulin as a parameter of the dysfunction of renal
tubules. The levels of urinary β-2 microglobulin were
found to be higher in newly diagnosed patients. Several
studies have demonstrated renal tubular parameters to
be abnormal during the early course of IDDM (7, 8).
High mean AER in total diabetic phatients in our series
may be explained by the poor metabolic control (9, 10).
Slightly higher mean AER in girls and significantly higher
AER in adolescent patients were found. In healthy
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subjects the reference value of AER changes according to
age and sex; the values of AER increase with age and the
normal values for females are significantly higher than for
males. This should be taken into consideration in the
assessment of diabetic nephropathy in IDDM (11).

extracellular matrix components in the glomerular and
tubular basement membrane (15, 16). Although there
were no significant differences between diabetic and
healthy subjects, we found the kidneys of the diabetic
patients to be slightly longer.

The occurrence of microalbuminuria and its relation to
puberty has also been reported in the course of diabetic
nephropathy (12). The higher values of AER for
adolescent patients found in our study may be an
indication of diabetic nephropathy.

Only four patients with persistent proteinuria with
mild hypertension and decreasing GFR were diagnosed as
having clinical nephropathy. Two patients with clinical
nephropathy had had DM for more than five years but the
other two patients had had overt nephropathy in the very
early stage of their disease. The prevalence found in this
study was 5.5%. ACE inhibitors were used in all four
patients, and in two, AER decreased in microalbuminuric
levels. However the other two showed a rapid
progression of renal failure. The progression of diabetic
renal disease depends on genetic factors and shows ethnic
variations (17, 19). Such early occurrence of renal failure
in our two patients may be due to an unexplained genetic
factor as well as the patients’ pubertal ages.

Over the pats two decades there has been increasing
interest in hypertension as a risk factor for diabetic renal
disease (13, 14). Higher blood pressure levels in our
adolescent patients were not thought to be related with
the progression of nephropathy because their blood
pressure levels were within the physiological limits for
their chronoloical age.
Kidney hypertrophy is a well known manifestation of
diabetic nephropathy, and it involves both glomerular and
tubular elements, due to progressive accumulation of

The incidence of diabetic nephropathy has been
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